Evidence map›Paper›PMID 38093395›Full record

SynthesisEuropean journal of medical research2023

Research progress of metabolomics in cervical cancer.

Yuhan Jia, Kun Zou, Lijuan Zou

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in European journal of medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Pharmacological assessment ofBioinformatics advances · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yuhan JiaDepartment of Radiotherapy, The Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China.ORCID https://orcid.org/0000-0003-3516-6337
Kun ZouDepartment of Radiotherapy, The First Hospital of Dalian Medical University, Dalian, Liaoning Province, China. zoukun29@163.com.
Lijuan ZouDepartment of Radiotherapy, The Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China. zoulijuan1963@dmu.edu.cn.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCervical cancer threatens women's health seriously. In recent years, the incidence of cervical cancer is on the rise, and the age of onset tends to be younger. Prevention, early diagnosis and specific treatment have become the main means to change the prognosis of cervical cancer patients. Metabolomics research can directly reflect the changes of biochemical processes and microenvironment in the body, which can provide a comprehensive understanding of the changes of metabolites in the process of disease occurrence and development, and provide new ways for the prevention and diagnosis of diseases.

objectivesThe aim of this study is to review the metabolic changes in cervical cancer and the application of metabolomics in the diagnosis and treatment.

methodsPubMed, Web of Science, Embase and Scopus electronic databases were systematically searched for relevant studies published up to 2022.

resultsWith the emergence of metabolomics, metabolic regulation and cancer research are further becoming a focus of attention. By directly reflecting the changes in the microenvironment of the body, metabolomics research can provide a comprehensive understanding of the patterns of metabolites in the occurrence and development of diseases, thus providing new ideas for disease prevention and diagnosis.

conclusionWith the continuous, in-depth research on metabolomics research technology, it will bring more benefits in the screening, diagnosis and treatment of cervical cancer with its advantages of holistic and dynamic nature.

Indexed as

Uterine Cervical NeoplasmsFemaleHumansMetabolomicsPrognosisTumor MicroenvironmentCervical cancerDiagnosisMetabolic regulationMetabolomicsTreatment

Identifiers

PMID38093395
PMCPMC10717910
OpenAlexW4389680639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.